Why the study?
Does perindopril reduce diabetes-induced plaque formation in diabetic apoE-deficient mice?
Does perindopril reduce diabetes-induced plaque formation in diabetic apoE-deficient mice?
ACE inhibition with perindopril prevents accelerated atherosclerosis and local renin-angiotensin system activation in diabetic apoE-deficient mice.
No takes yet. Share an insight, caveat, or question.
Does not support perindopril for diabetic atherosclerosis in patients; leaves open translation from apoE-deficient mouse models.
Candido et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: